| Sep 22 2014 |
Major Damages Award in Pelvic Mesh Case Underscores the Critical Role of Internal Email in Jury Trials |
Covington & Burling LLP |
| Sep 20 2014 |
Court Rejects FDA’s Interpretation of the Statute’s Device Definition as “Erroneous and Unreasonable” |
Covington & Burling LLP |
| Sep 19 2014 |
DEA Controlled Substance Disposal Requirements Take Effect October 9, 2014 |
Beveridge & Diamond PC |
| Sep 19 2014 |
Internet/Social Media Platforms: FDA Draft Guidance |
Giordano, Halleran & Ciesla, P.C. |
| Sep 16 2014 |
President Obama’s Response to the Ebola Crisis |
Covington & Burling LLP |
| Sep 15 2014 |
340B Federal Drug Pricing Program September Update: Self-Disclosures |
McDermott Will & Emery |
| Sep 13 2014 |
Judge Requires PhRMA To Initiate New 340B Orphan Drug Lawsuit to Challenge Interpretive Rule |
Covington & Burling LLP |
| Sep 13 2014 |
Looking Towards the Future of Pharmaceuticals in Africa |
Covington & Burling LLP |
| Sep 12 2014 |
National Institute of Standards and Technology (NIST) Issues Draft Report Enumerating Risks and Protections to Consider When Evaluating Mobile Apps for Your Enterprise |
Mintz |
| Sep 11 2014 |
FutureGen Receives EPA Permits for Underground Injection |
Greenberg Traurig, LLP |
| Sep 11 2014 |
FDA Focuses on Sex-Specific Data in Medical Device Clinical Trials |
Covington & Burling LLP |
| Sep 11 2014 |
FDA Publishes “Purple Book” for Biologicals/Biosimilars |
Schwegman, Lundberg & Woessner, P.A. |
| Sep 11 2014 |
Indefiniteness After The Supreme Court Nautilus Decision – A Very “Delicate Balance” |
Schwegman, Lundberg & Woessner, P.A. |
| Sep 11 2014 |
Court of Federal Claims Stays Decision Requiring Commercial Item Contractor to Comply with Non-Commercial Practices |
Covington & Burling LLP |
| Sep 10 2014 |
Trouble Ahead For On-the-Job Post-Accident Drug Testing? |
Jackson Lewis P.C. |
| Sep 10 2014 |
Ariosa Diagnostics v. Isis Innovation Limited: Final Written Decision (Motion to Amend) IPR2012-00022 |
Faegre Drinker |
| Sep 9 2014 |
FTC Brings its First Post-Actavis Suit re: Pharmaceutical Patent Litigation |
Covington & Burling LLP |
| Sep 9 2014 |
FDA Issues Draft Guidance Regarding Controlled Correspondence from Generics Manufacturers |
Mintz |
| Sep 9 2014 |
Decision Requiring Commercial-Item Suppliers to Comply with Non-Standard Terms under the Federal Acquisition Regulation (FAR) Is Stayed Pending Appeal at Federal Circuit |
Covington & Burling LLP |
| Sep 8 2014 |
Wage & Hour Claims: A Look Back on the First Half of 2014 |
Gilbert LLP |
| Sep 5 2014 |
Australia: Cancer Voices v Myriad Opinion Affirmed |
Schwegman, Lundberg & Woessner, P.A. |
| Sep 5 2014 |
Telehealth and Health IT Policy: Considerations for Stakeholders |
Mintz |
| Sep 3 2014 |
Government Issues New Rules for Religious Employers, But Health Plans, Third Party Administrators (TPAs), and Pharmacy Benefits Managers (PBMs) are still on the Hook to Provide Contraceptive Coverage |
Mintz |
| Sep 2 2014 |
EU Court Of Justice Further Clarifies Definition Of Medicinal Products – And Raises New Questions |
Covington & Burling LLP |
| Sep 2 2014 |
China Issues Multiple Final Rules and Proposals to Implement Recent Revisions to its Core Medical Device Regulation |
Covington & Burling LLP |
| Sep 2 2014 |
Summary of FDA Advertising and Promotion Enforcement Activities – September 2, 2014 |
Covington & Burling LLP |
| Sep 2 2014 |
The Increasingly Murky World of 340B Drug Discount Program: What’s Next? |
Mintz |
| Sep 2 2014 |
Two-Party Market: Presumption of Confusion and Injury |
McDermott Will & Emery |
| Aug 29 2014 |
Pharmacies Avoid False Claims Act Suit: Fox Rx Inc. v. Omnicare Inc. et al. |
Covington & Burling LLP |
| Aug 28 2014 |
Hawaii G-M-O: Kauai County GMO Regs Struck Down in Federal Court |
Mintz |
| Aug 28 2014 |
Third Circuit Holds Irreparable Harm May Not Be Presumed In Lanham Act False Advertising Cases To Establish Entitlement To Injunctive Relief |
Proskauer Rose LLP |
| Aug 27 2014 |
Genus Claims Require Disclosure of “Representative Species Encompassing the Breadth of the Genus” |
McDermott Will & Emery |
| Aug 27 2014 |
Selection Invention Found Unpatentable for Obviousness-Type Double Patenting |
Sterne, Kessler, Goldstein & Fox P.L.L.C. |
| Aug 27 2014 |
Tennessee Employer Gets New Trial to Prove Drug Tests Were Not Medical Examinations or Disability-Related Inquiries |
Jackson Lewis P.C. |
| Aug 26 2014 |
Health Care Law Update - August 25, 2014 |
Mintz |
